Letter to the Editor: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.
사설/논평
0/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.8%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
APA
Nam H, Lee SW (2025). Letter to the Editor: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.. Hepatology (Baltimore, Md.). https://doi.org/10.1097/HEP.0000000000001562
MLA
Nam H, et al.. "Letter to the Editor: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.." Hepatology (Baltimore, Md.), 2025.
PMID
41134318 ↗
같은 제1저자의 인용 많은 논문 (3)
- Editorial: Residual HCC Risk After Hepatitis C Cure: Can Polygenic Risk Scores Refine Surveillance?
- Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab.
- Taurine Synthesis by 2-Aminoethanethiol Dioxygenase as a Vulnerable Metabolic Alteration in Pancreatic Cancer.